Xiamen Amoytop Biotech(688278.SH): "Electronic Pen-type Injector" Obtains Medical Device Registration Certificate
Tebao Bio (688278.SH) issued an announcement, stating that the company recently received the medical...
Xiamen Amoytop Biotech (688278.SH) announced that the company has recently received a medical device registration certificate issued by the Fujian Province Food and Drug Administration, involving the product "electronic pen-type injector." The acquisition of the above-mentioned medical device registration certificate further enriches the company's product range, helping to better meet market demand and enhance the overall competitiveness of the company's products.
Related Articles

Morgan Stanley: Optimistic about the prospects of strategic transformation + positioning better than market expectations, giving Appian (APPN.US) a "hold" rating.

Roche (RHHBY.US) will acquire 89bio (ETNB.US) for up to $3.5 billion to increase its presence in the weight loss drug market.

Home Depot, Inc. (HD.US) dividends are expected to continue to grow, highlighting long-term investment value.
Morgan Stanley: Optimistic about the prospects of strategic transformation + positioning better than market expectations, giving Appian (APPN.US) a "hold" rating.

Roche (RHHBY.US) will acquire 89bio (ETNB.US) for up to $3.5 billion to increase its presence in the weight loss drug market.

Home Depot, Inc. (HD.US) dividends are expected to continue to grow, highlighting long-term investment value.
